Agenus Inc. (AGEN) vs Rezolute, Inc. (RZLT)
Agenus Inc. and Rezolute, Inc. are both Biotechnology companies. Agenus Inc. and Rezolute, Inc. are of similar size ($379.4M and $375.3M). Rezolute, Inc. has negative trailing earnings, so its P/E is not meaningful; Agenus Inc. trades at 3.2×. Agenus Inc. has the higher net margin (69.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Agenus Inc. leads on 9 and Rezolute, Inc. on 3.
Valuation
Profitability
| Metric | AGEN | RZLT | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.52% | 0.00% | 65.16% |
| Operating margin | 27.28% | 0.00% | 0.00% |
| Net margin | 69.18% | 0.00% | 0.00% |
| Free cash flow margin | (73.97%) | 0.00% | 0.00% |
| Return on equity | (33.86%) | (81.73%) | (57.72%) |
| Return on assets | 51.30% | (74.01%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack